Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Completed · Phase 2

Conditions studied: Colorectal Cancer, Metastatic Cancer

In brief

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have colorectal cancer that has spread to the liver.

Key facts

Study ID
NCT00033748
Run by
Alliance for Clinical Trials in Oncology
People needed
56
Starts
2001-12-01
Expected to finish
2010-06-01
Last updated by the study team
2016-07-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.